Liposomal aerosols in the management of pulmonary infections

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 9, Issue 1, 1996, Pages 111-122

  Gilbert, Brian E ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

aerosol; amphotericin B; liposomes; pulmonary diseases; treatment

Indexed keywords

AMIKACIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIOXIDANT; CEFTAZIDIME; CLOFAZIMINE; ETHAMBUTOL; GENTAMICIN; ISONIAZID; KANAMYCIN; LIPOSOME; NYSTATIN; PYRAZINAMIDE; RIFAMYCIN; TOBRAMYCIN;

AEROSOL; ANIMAL CELL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; CANDIDIASIS; CRYPTOCOCCOSIS; DRUG FORMULATION; DRUG PENETRATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG INFECTION; MOUSE; NONHUMAN; PHARMACOKINETICS; REVIEW;

EID: 0029874102     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.1996.9.111     Document Type: Review

References (69)

1. AGARWAL, A., KANDPAL, H., GUPTA, H.P., SINGH, N.B., and GUPTA, C.M. (1994). Tuftsin-bearing liposomes as rifampin vehicles in treatment of tuberculosis in mice. Antimicrob. Agents Chemother. 38:588-593.
2. AGUADO, J.M., HIDALGO, M., MOYA, I., ALCAZAR, J.M., JIMENEZ, M.J., and NORIEGA, A.R. (1993). Ventricular arrhythmias with conventional and liposomal amphotericin. Lancet 342:1239.
3. ALLEN, S.D., SORENSEN, K.N., NEJDL, M.J., and PROFFITT, R.T. (1994). Efficacy of aerosolized liposomal amphotericin B (amBisome(r)) as a prophylactic treatment in an immune compromised murine model of pulmonary aspergillosis. J. Control Release 28:348-349.
4. ANDERSON, P.M., HASZ, D., DICKRELL, L., and SENCER, S. (1992). Interleukin-2 in liposomes-Increased intravenous potency and less pulmonary toxicity in the rat. Drug Dev. Res. 27:15-31.
5. ANDERSON, P.M., HANSON, D.C., HASZ, D.E., HALET, M.R., BLAZAR, B.R., and OCHOA, A.C. (1994). Cytokines in liposomes - preliminary studies with IL-1, IL-2, IL-6, GM-CSF and interferon-gamma. Cytokine 6:92-101.
6. ANDRIES, K., DEWINDT, B., SNOEKS, J., WILLEBRORDS, R., STOKBROEKX, R., and LEWI, P.J. (1991). A comparative test of fifteen compounds against all known human rhinoviras serotypes as a basis for a more rational screening program. Antiviral Res. 16:213-225.
7. BAKKERWOUDENBERG, I.A.J.M., STORM, G., and WOODLE, M.C. (1994). Liposomes in the treatment of infections. J. Drug Targeting 2:363-371.
8. BALDWIN, D.R., HONEYBOURNE, D., and WISE, R. (1992). Pulmonary disposition of antimicrobial agents: Methodological considerations. Antimicrob. Agents Chemother. 36:1171-1175.
9. BARACH, A.L., MOLOMUT, M., and SOROKA, M. (1942). Inhalation of nebulized promin in experimental tuberculosis. Am. Rev. Tuberc. 46:268-276.
10. BERENDT, R.F., LONG, G.G., and WALKER, J.S. (1975). Treatment of respiratory Klebsiella pneumoniae infection in mice with aerosols of kanamycin. Antimicrob. Agents Chemother. 8:585-590.
11. BRAJTBURG, J., POWDERLY, W.G., KOBAYASHI, G.S., and MEDOFF, G. (1990). Amphotericin B: Delivery systems. Antimicrob Agents Chemother. 34:381-384.
12. BRESSOLLE, F., DE LA COUSSAYE, J., AYOUB, R., FABRE, D., GOMENI, R., SAISI, G., ELEDJAM, J., and GALTIER, M. (1992). Endotracheal and aerosol administrations of ceftazidime in patients with nosocomial pneumonia: Pharmacokinetics and absolute bioavailability. Antimicrob. Agents Chemother. 36:1404-1411.
13. BRISCOE, P., CANIGGIA, I., GRAVES, A., BENSON, B., HUANG, L., TANSWELL, A.K., and FREEMAN, B.A. (1995). Delivery of superoxide dismutase to pulmonary epithelium via pH-sensitive liposomes. Am. J. Physiol.-Lung Cell M. Ph. 12:L374-L380.
14. BRYNESTAD, K., BABBITT, B., HUANG, L., and ROUSE, B.T. (1990). Influence of peptide acylation, liposome incorporation, and synthetic immunomodulators on the immunogenicity of a 1-23 peptide of glycoprotein D of herpes simplex virus: Implications of subunit vaccines. J. Virol. 64:680-685.
15. CLEMONS, K.V., and STEVENS, D.A. (1991). Efficacies of liposomal formulation (AmBisome; AmBi) and deoxycholate suspension of amphotericin B (Fungizone; F) against murine blastomycosis. ICAAC 31:196 (Abstract).
16. CLEMONS, K.V., and STEVENS, D.A. (1993). Comparison of a liposomal amphotericin B formulation (amBisome) and deoxycholate amphotericin B (Fungizone) for the treatment of murine paracoccidioidomycosis. J. Med. Vet. Mycol. 31:387-394.
17. COUCH, R.B., and KASEL, J.A. (1983). Immunity to influenza in man. Annu. Rev. Microbiol. 37:529-549.
18. DAVIS, J.M., ROSENFELD, W.N., KOO, H.C., and GONENNE, A. (1994). Pharmacologic interactions of exogenous lung surfactant and recombinant human Cu/Zn superoxide dismutase. Pediatr. Res. 35:37-40.
19. DIAMOND, R.D. (1991). The growing problem of mycoses in patients infected with the human immunodeficiency virus. Rev. Infect. Dis. 13:480-486.
20. EL GUINK, N., KRIS, R.M., GOODMAN-SNITKOFF, G., SMALL, JR., and MANNIONO, R.J. (1989). Intranasal immunization with proteoliposomes protects against influenza. Vaccine 7:147-151.
21. FIEL, S.B. (1995). Aerosol delivery of antibiotics to the lower airways of patients with cystic fibrosis. Chest 107:S61-S64.
22. FRANCIS, P., LEE, J.W., HOFFMAN, A., PETER, J., FRANCESCONI, A., BACHER, J., SHELHAMER, J., PIZZO, P.A., and WALSH, T.J. (1994). Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: - The potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection. J. Infect. Dis. 169:356-368.
23. GARCON, N.M.J., and SIX, H.R. (1991). Universal vaccine carrier - Liposomes that provide T-dependent help to weak antigens. J. Immunol. 146:3697-3702.
24. GILBERT, B.E., and KNIGHT, V. (1990). Ribavirin aerosol as the treatment for influenza. Drugs Today 26:195-205.
25. GILBERT, B.E., SIX, H.R., WILSON, S.Z., WYDE, P.R., and KNIGHT, V. (1988). Small particle aerosols of enviroxime-containing liposomes. Antiviral Res. 9:355-365.
26. GILBERT, B.E., WYDE, P.R., and WILSON, S.Z. (1992). Aerosolized liposomal amphotericin B for treatment of pulmonary and systemic Cryptococcus neoformans infections in mice. Antimicrob. Agents Chemother. 36:1466-1471.
27. GILBERT, B.E., WYDE, P.R., LOPEZ-BERESTEIN, G., and WILSON, S.Z. (1994). Aerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice. Antimicrob. Agents Chemother. 38:356-359.
28. ++ superoxide dismutase. Chest 104:811-815.
29. GUILLEMALN, R., LAVARDE, V., AMREIN, C., CHEVALIER, P., GUINVARCH, A., and GLOTZ, D. (1994). Aspergillosis after pulmonary, cardiac and renal transplantation. Pathol. Biol. 42:661-669.
30. KENNET, T., ZILTENER, H.J., FREI, K., and PETERHANS, E. (1992). A kinetic study of immune mediators in the lungs of mice infected with influenza-A virus. J Immunol 149:932-939.
31. HOSTETLER, K.Y., PARKER, S., SRIDHAR, C.N., MARTIN, M.J., LI, J.L., STUHMILLER, L.M., VANWUK, G.M.T., VANDENBOSCH, H., GARDNER, M.F., ALDERN, K.A., and RICHMAN, D.D. (1993). Acyclovir diphosphate dimyristoylglycerol - a phospholipid prodrug with activity against acyclovir-resistant herpes simplex virus. Proc. Natl. Acad. Sci. U.S.A. 90:11835-11839.
32. HOSTETLER, K.Y., KORBA, B.E., SRIDHAR, C.N., and GARDNER, M.F. (1994). Antiviral activity of phosphatidyl-dideoxycytidine in hepatitis B-infected cells and enhanced hepatic uptake in mice. Antiviral Res. 24:59-67.
33. KEDAR, E., RUTKOWSKI, Y., BRAUN, E., EMANUEL, N., and BARENHOLZ, Y. (1994). Delivery of cytokines by liposomes. 1. Preparation and characterization of interleukin-2 encapsulated in long-circulating sterically stabilized liposomes. J. Immunother. 16:47-59.
34. KNIGHT, V., and GILBERT, B. (1988). Antiviral therapy with small particle aerosols. Eur. J. Clin. Microbiol. Infect. Dis. 7:721-731.
35. KNIGHT, V., GILBERT, B.E., and WILSON, S.Z. (1986). Ribavirin smal particle aerosol treatment of influenza and respiratory syncytial virus infections. In T. Stapleton, Studies with a Broad Spectrum Antiviral Agent. Royal Society of Medicine Series, New York, ed. 37-56.
36. LAING, R.B.S., MILNE, L.J.R., LEEN, C.L.S., MALCOLM, G.P., and STEERS, A.J.W. (1994). Anaphylactic reactions to liposomal amphotericin. Lancet 344:682.
37. LECONTE, P., POTEL, G., PELTIER, P., HOREAU, D., CAILLON, J., JUVIN. M.E., KERGUERIS, M.F., BUGNON, D., and BARON, D. (1993). Lung distribution and pharmacokinetics of aerosolized tobramycin. Am. Rev. Respir. Dis. 147:1279-1282.
38. LEVINE, S.J., WALSH, T.J., MARTINEZ, A., EICHACKER, P.Q., LOPEZ-BERESTEIN, G., and NATANSON, C. (1991). Cardiopulmonary toxicity after liposomal amphotericin B infusion. Ann. Intern Med. 114:664-666.
39. LOPEZ-BERESTEIN, G. (1988). Liposomes as carriers of antifungal drugs. Ann. NY Acad Sci. 544:590-597.
40. LOPEZ-BERESTEIN, G., MEHTA, R., HOPPER, R.L., MILLS, K., KASI, L., MEHTA, K., FAINSTEIN, V., LUNA, M., HERSH, E.M., and JULIANO, R. (1983). Treatment and prophylaxis of disseminated infection due to Candida albicans in mice with liposome-encapsulated amphotericin B. J. Infect. Dis. 147:939-945.
41. MAGALLANES, M., KIJKSTRA, J., and FIERER, J. (1993). Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis. Antimicrob. Agents Chemother. 37:2292-2297.
42. MAJUMDAR, S., FLASHER, D., FRIEND, D.S., NASSOS, P., YAJKO, D., HADLEY, W.K., and DUZGUNES, N. (1992). Efficacies of liposome-encapsulated streptomycin and ciprofloxacin against Mycobacterium avium-M. intracellulare complex infections in human peripheral blood monocyte/macrophages. Antimicrob. Agents Chemother. 36:2808-2815.
43. MAKHOUL, I.R., MERZBACH, D., LICHTIG, C., and BERANT, M. (1993). Antibiotic treatment of experimental Pseudomonas aeruginosa pneumonia in guinea pigs - comparison of aerosol and systemic administration. J. Infect. Dis. 168:1296-1299.
44. MBAWUIKE, I.N., PHAM-NGUYEN, K., CABALLERO, D., ACUNA, C., GILBERT, B., PIETROBON, J.F., and HARMON, M.W. (1995). Costimulation of IFN-[gamma] and influenza virus-specific CTL in aged mice with novel adjuvants, CTB/CT and MPL. 9th Internat. Congress Immunol (Abstract).
45. NIGHTINGALE, S.D., SALETAN, S.L., SWENSON, C.E., LAWRENCE, A.J., WATSON, D.A., PILKIEWICZ, F.G., SILVERMAN, E.G., and CAL, S.X. (1993). Liposome-encapsulated gentamicin treatment of Mycobacterium avium-Mycobacterium intracellulare complex bacteremia in AIDS patients. Antimicrob. Agents Chemother. 37:1869-1872.
46. NIKI, Y., BERNARD, E.M., EDWARDS, F.F., SCHMITT, H.J., YU, B., and ARMSTRONG, D. (1991). Model of recurrent pulmonary aspergillosis in rats. J. Clin. Microbiol. 29:1317-1322.
47. ODA, T., AKAIKE, T., HAMAMOTO, T., SUZUKI, F., HIRANO, T., and MAEDA, H. (1989). Oxygen radicals in influenza-induced pathogenesis and treatment with pyran polymer-conjugated SOD. Science 244:974-976.
48. OMRI, A., BEAULAC, C., BOUHAJIB, M., MONTPLAISIR, S., SHARKAWI, M., and LAGACE, J. (1994). Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 38:1090-1095.
49. PROFFITT, R.T., SATORIUS, A., CHIANG, S., SULLIVAN, L., and ADLER-MOORE, J.P. (1991). Pharmacology and toxicology of a liposomal formulation of amphotericin B (AmBisome) in rodents. J. Antimicrob. Chemother. 28(Suppl. B):49-61.
50. RINGDEN, O., TOLLEMAR, J., DAHLLOF, G., and TYDEN, G. (1994). High cure rate of invasive fungal infections in immunocompromised children using AmBisome. Transplant. Proc. 26:175-177.
51. SCHWENDENER, R.A., GOWLAND, P., HORBER, D.H., ZAHNER, R., SCHERTLER, A., and SCHOTT, H. (1994). New lipophilic alkyl/acyl dinucleoside phosphates as derivatives of 3′-azido-3′-deoxythymidine: Inhibition of HIV-1 replication in vitro and antiviral activity against Rauscher leukemia virus infected mice with delayed treatment regimens. Antiviral Res 24:79-93.
52. SHEK, P.N., SUNTRES, Z.E., and BROOKS, J.I. (1994). Liposomes in pulmonary applications: Physicochemical considerations, pulmonary distribution and antioxidant delivery. J. Drug Targeting 2:431-442.
53. SIDWELL, R.W., SMEE, D.F., HUFFMAN, J.H., BAILEY, K.W., WARREN, R.P., BURGER, R.A., and PENNEY, C.L. (1995). Antiviral activity of an immunomodulatory lipophilic desmuramyl dipeptide analog. Antiviral Res. 26:145-159.
54. SIX, H.R., GILBERT, B.E., WYDE, P.R., WILSON, S.Z., and KNIGHT, V. (1989). Liposomes as carriers of enviroxime for use in aerosol therapy of rhinovims infections. In G. Lopez-Berestein, and I. Fidler, eds. Liposomes in the Therapy of Infectious Diseases and Cancer. Alan R. Liss, New York, 229-238.
55. SPERBER, S.J., and HAYDEN, F.G. (1988). Chemotherapy of rhinovirus colds. Antimicrob. Agents Chemother. 32:409-419.
56. STANIMIROVIC, D.B., MARKOVIC, M., MICIC, D.V., SPATZ, M., and MRSULJA, B.B. (1994). Liposome-entrapped superoxide dismutase reduces ischemia reperfusion 'oxidative stress' in gerbil brain. Neurochem. Res. 19:1473-1478.
57. TADAKUMA, T., IKEWAKI, N., YASUDA, T., TSUTSUMI, M., ASITO, S., and SAITO, K. (1985). Treatment of experimental salmonellosis in mice with streptomycin entrapped in liposomes. Antimicrob. Agents Chemother, 28:28-32.
58. TAG EL-DIN, M.A., PALMER, L.B., EL-TAYEB, M.N., KHALIL, I., and GABR, M.S. (1994). Nebulizer therapy with antibiotics in chronic suppurative lung disease. J. Aerosol Med. 7:345-350.
59. TURNER, R.B., DUTKO, F.J., GOLDSTEIN, N.H., LOCKWOOD, G., and HAYDEN, F.G. (1993). Efficacy of oral WIN 54954 for prophylaxis of experimental rhinovirus infection. Antimicrob. Agents Chemother. 37:297-300.
60. VANETTEN, E.W.M., VANDENHEUVELDEGROOT, C., and BAKKERWOUDENBERG, I.A.J.M. (1993). Efficacies of amphotericin-B-desoxycholate (Fungizone), liposomal amphotericin-B (AmBisome) and fluconazole in the treatment of systemic candidosis in immunocompetent and leucopenic mice. J. Antimicrob. Chemother. 32:723-739.
61. VANROOIJEN, N. (1990). Liposomes as carrier and immunoadjuvant of vaccine antigens. Bacterial Vaccines 13:255-279.
62. 99mtechnetium-labelled beclomethasone dipropionate dilauroylphosphatidylcholine liposome aerosol in normal volunteers. Int. J. Pharm. 115:209-216.
63. WALDMAN, R.H., JURGENSEN, P.F., OLSEN, G.N., GANGULY, R., and JOHNSON, J.E. III (1973). Immune response of the human respiratory tract I. Immunoglobulin levels and influenza virus vaccine antibody response. J. Immunol. 111:38-41.
64. WALTHER, F.J., DAVID-CU, R., SUPNET, M.C., LONGO, M.L., FAN, B.R., and BRUNI, R. (1993). Uptake of antioxidants in surfactant liposomes by cultured alveolar type II cells is enhanced by SP-A. Am. J. Physiol. 265:L330-L339.
65. WASAN, K.M., and LOPEZBERESTEIN, G. (1995). The past, present, and future uses of liposomes in treating infectious diseases. Immunopharmacol. Immunotoxicol. 17:1-15.
66. WELSH, N., MARGULIS, B., BENDTZEN, K., and SANDLER, S. (1994). Liposomal delivery of antioxidant enzymes protects against hydrogen peroxide- but not interleukin-1 beta-induced inhibition of glucose metabolism in rat pancreatic islets. J. Endocrinol. 143:151-156.
67. WILSON, S.Z., KNIGHT, V., WYDE, P.R., DRAKE, S., and COUCH, R.B. (1980). Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice. Antimicrob. Agents Chemother. 17:642-648.
68. WYDE, P.R., COUCH, R.B., MACKLER, B.F., CATE, T.R., and LEVY, B.M. (1977). Effects of low- and high-passage influenza virus infection in normal and nude mice. Infect. Immun. 15:221-229.
69. WYDE, P.R., SIX, H.R., WILSON, S.Z., GILBERT, B.E., and KNIGHT, V. (1988). Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes. Antimicrob. Agents Chemother. 32:890-895.